{"result": "(\"entity\"<|>MEDULLARY THYROID CARCINOMA<|>EVENT<|>Medullary thyroid carcinoma is a type of cancer that can occur sporadically or in familial forms, often associated with elevated calcitonin levels.)\n##\n(\"entity\"<|>THYROID GLAND<|>GEO<|>The thyroid gland is an endocrine organ that produces hormones regulating metabolism and is involved in conditions like medullary thyroid carcinoma.)\n##\n(\"entity\"<|>BRAUCKHOFF M<|>PERSON<|>Brauckhoff M is a researcher who has contributed to studies on multiple endocrine neoplasia and medullary thyroid carcinoma.)\n##\n(\"entity\"<|>GIMM O<|>PERSON<|>Gimm O is a researcher involved in the study of medullary thyroid carcinoma and its genetic mutations.)\n##\n(\"entity\"<|>WEISS CL<|>PERSON<|>Weiss CL is a researcher who has published work on the clinical manifestations of medullary thyroid carcinoma.)\n##\n(\"entity\"<|>UKKAT J<|>PERSON<|>Ukkat J is a researcher who has studied the mutation of the RET oncogene in relation to medullary thyroid carcinoma.)\n##\n(\"entity\"<|>SEKULLA C<|>PERSON<|>Sekulla C is a researcher who has contributed to the understanding of multiple endocrine neoplasia and its implications for medullary thyroid carcinoma.)\n##\n(\"entity\"<|>BRAUCKHOFF K<|>PERSON<|>Brauckhoff K is a researcher who has worked on the clinical aspects of medullary thyroid carcinoma.)\n##\n(\"entity\"<|>AMERICAN THYROID ASSOCIATION<|>ORGANIZATION<|>The American Thyroid Association is a professional organization that provides guidelines for the management of thyroid disorders, including medullary thyroid carcinoma.)\n##\n(\"relationship\"<|>BRAUCKHOFF M<|>MEDULLARY THYROID CARCINOMA<|>Brauckhoff M has conducted research on medullary thyroid carcinoma and its clinical manifestations<|>7)\n##\n(\"relationship\"<|>GIMM O<|>MEDULLARY THYROID CARCINOMA<|>Gimm O has studied the genetic mutations associated with medullary thyroid carcinoma<|>7)\n##\n(\"relationship\"<|>WEISS CL<|>MEDULLARY THYROID CARCINOMA<|>Weiss CL has published research on the clinical aspects of medullary thyroid carcinoma<|>7)\n##\n(\"relationship\"<|>UKKAT J<|>MEDULLARY THYROID CARCINOMA<|>Ukkat J has researched the RET oncogene mutation related to medullary thyroid carcinoma<|>7)\n##\n(\"relationship\"<|>SEKULLA C<|>MEDULLARY THYROID CARCINOMA<|>Sekulla C has contributed to studies on multiple endocrine neoplasia and its relation to medullary thyroid carcinoma<|>7)\n##\n(\"relationship\"<|>BRAUCKHOFF K<|>MEDULLARY THYROID CARCINOMA<|>Brauckhoff K has worked on the clinical implications of medullary thyroid carcinoma<|>7)\n##\n(\"relationship\"<|>AMERICAN THYROID ASSOCIATION<|>MEDULLARY THYROID CARCINOMA<|>The American Thyroid Association provides guidelines for the management of medullary thyroid carcinoma<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: si es posible sin              • Cribado de feocromocitoma                           con nódulos tiroideos”. Así pues, la opción A se puede considerar falsa.\n                                                  ocasionar hipoparatiroidismo                  e hiperparatiroidismo primario\n                                                                                                a partir de los 11 años                             Sin embargo, los expertos de este panel estaban de acuerdo en su determinación si la posi-\n                                                • Tiroidectomía total a los                                                                         bilidad de carcinoma medular era elevada, como es el caso de citologías sospechosas, sin\n                                                  5 años (antes si hay aumento                                                                      rasgos consistentes de papilar, o en pacientes con historia familiar de carcinoma medular,\n                                  C634            de calcitonina)                                                                                   por   lo que tanto las opciones B como                  C pueden       considerarse ciertas           (opción D correcta).\n              Alto               A883F          • Linfadenectomía total                       • Igual que riesgo máximo\n                                                  profiláctica si calcitonina > 40                                                                  Referencias:\n                                                                                                                                                    • Chambon G, Alovisetti C, Idoux-Louche C, Reynaud C, Rodier M, Guedj AM, et al. The use of preoperative routine measurement\n                                                  pg/ml o cN1                                                                                         of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive\n                                                                                                                                                      patients. J Clin Endocrinol Metab. 2011;96:75-81.\n                                                                                              • Comenzar a los 5 años:                              • Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, et al. Predictive value of serum calcitonin levels for preoperative\n                                                • Tiroidectomía total profiláctica              exploración física, ecografía                         diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab.\n                                                  cuando se eleve la calcitonina o              cervical y calcitonina-CEA cada                       2007;92:450-5.\n                                                                                                                                                    • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management\n      Moderado               Resto                durante la infancia si los padres             6 meses el primer año, luego                          Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines\n                                                  prefieren evitar seguimiento                  anual si es normal                                    Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.\n                                                  indefinido                                  • Cribado de feocromocitoma\n                                                                                                y HPP a partir de los 16 años\n     CEA: antígeno carcinoembrionario; HPP: hiperparatiroidismo primario.                                                                       43  En   relación con el carcinoma medular de tiroides,                             es cierto que:\n     Referencias:                                                                                                                                   A.  Las formas familiares explican más del 80% de los casos y son                               más frecuentes que la\n     • Brauckhoff M, Gimm O, Weiss CL, Ukkat J, Sekulla C, Brauckhoff K, et al. Multiple endocrine neoplasia 2B syndrome due to codon 918               forma esporádica.\n       mutation: clinical manifestation and course in early and late onset disease. World J Surg. 2004;28:1305-11.\n     • Brauckhoff M, Machens A, Lorenz K, Bjoro T, Varhaug JE, Dralle H. Surgical curability of medullary thyroid cancer in multiple endocrine      B.  La mutación del oncogen RET más frecuente en el MEN2B es la del codón 634.\n       neoplasia 2B: a changing perspective. Ann Surg. 2015;259:800-6.\n     • Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab.         C.  En el MEN2A, los feocromocitomas aparecen habitualmente más tarde que el carcinoma\n       2010;95:2655-63.                                                                                                                                 medular, si bien pueden aparecer en cualquier momento.\n     • Pacini F, Castagna MG, Cipri C, Schlumberger M. Medullary thyroid carcinoma. Clinical Oncology. 2010;22(6):475-85.\n     • Wells SA, Asa SL, Dralle H, Elisei R, Evan DB, Gagel RF, et al. Revised American Thyroid Association Guidelines for the Management of        D.  Los niveles de calcitonina al diagnóstico no predicen la supervivencia de estos tumores.\n       Medullary Thyroid Carcinoma. The American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Thyroid.\n       2015;25(6):567-610.\n\n\n\n180                                                                                                                                                                                                                                                                                          181\n---\n                                                                                                                                                                                                                                           TIROIDES  3\n\n\n\n     COMENTARIO                                                                                                                              44  En relación con la utilización de la PET con 18F-FDG en los carcinomas\n     Los carcinomas medulares de tiroides se pueden presentar de forma esporádica o como                                                         diferenci\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}